3D Echocardiography and Cardiovascular Prognosis in Mitral Regurgitation
-
- STATUS
- Recruiting
-
- participants needed
- 200
-
- sponsor
- Haukeland University Hospital
Summary
The 3D-PRIME study will analyse whether use of 3D echocardiography can improve risk stratification and cardiovascular outcome in patients with mitral regurgitation of different etiologies.
Details
Condition | VALVULAR HEART DISEASE, Mitral Regurgitation |
---|---|
Age | 18years - 100years |
Treatment | Use of 3D echocardiography in patient follow-up |
Clinical Study Identifier | NCT04442828 |
Sponsor | Haukeland University Hospital |
Last Modified on | 16 February 2024 |
How to participate?
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.